The application of molecular markers (e.g., the application of BRAF growth promoter in thyroid papillary carcinoma) and IHC (e.g., the application of CD-10 in RCC) may be further helpful in the diagnosis of FNAB [57,58,59,60]. This evidence concerns the gene BRAF and thyroid gland papillary carcinoma.